🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Courtney Johnson

Emory University

ORCID: 0000-0001-8903-1513

Also affiliated with Macula Vision Research Foundation

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A quality‐adjusted survival time without symptoms or toxicities analysis of glasdegib plus low‐dose cytarabine versus low‐dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy”.

A quality‐adjusted survival time without symptoms or toxicities analysis of glasdegib plus low‐dose cytarabine versus low‐dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy

Cancer(2020)10.1002/cncr.33072

N/A

0DataRank · unranked

8 citations

Timothy Bell, Young‐Min Kwon, Joseph C. Cappelleri, Courtney Johnson, Helen Bhattacharyya +3 more

BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03497-1

N/A

0DataRank · unranked

15 citations

Colin D. Angell, Himanshu Savardekar, Debasish Sundi, David Abood, Brooke Benner +15 more

Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate

Nanomaterials(2024)10.3390/nano14181509

N/A

0DataRank · unranked

1 citations

Gabriella Lapurga, Steven Sun, Courtney Johnson, Himanshu Savardekar, Isaac V. Rampersaud +7 more